Imaging atherosclerosis in the vulnerable patient

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 1, 2007, Pages 143-146

  Lucignani, Giovanni ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN A5 TC 99M; DIADENOSINE TETRAPHOSPHATE; LIPOCORTIN 5; MONOFLUOROMETHYLENE DIADENOSINE 5',5''' TETRAPHOSPHATE F18; TECHNETIUM 99M; VASCULAR CELL ADHESION MOLECULE 1; VINP 28;

ATHEROSCLEROSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; IMAGING SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ULTRASOUND;

ATHEROSCLEROSIS; DIAGNOSTIC IMAGING; HUMANS; IMAGE ENHANCEMENT; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS;

EID: 33845363582     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0301-5     Document Type: Review

References (14)

1. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-72.
2. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003;108:1772-8.
3. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, et al. From vulnerable plaque to vulnerable patient - Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 2006;98 (2A):2H-15H3.
4. Budoff MJ, Gopal A, Gopalakrishnan D. Cardiac computed tomography: diagnostic utility and integration in clinical practice. Clin Cardiol 2006;29(9 Suppl 1):I4-I14.
5. Bengel FM. Atherosclerosis imaging on the molecular level. J Nucl Cardiol 2006;13:111-8.
6. Ben-Haim S, Israel O. PET/CT for atherosclerotic plaque imaging. Q J Nucl Med Mol Imaging 2006;50(1):53-60.
7. Davies JR, Rudd JH, Weissberg PL, Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 2006;47(8 Suppl):C57-C68.
8. Purushothaman KR, Sanz J, Zias E, Fuster V, Moreno PR. Atherosclerosis neovascularization and imaging. Curr Mol Med 2006;6(5):549-56.
9. Sirol M, Fuster V, Fayad ZA. Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment. Curr Mol Med 2006;6(5):541-8.
10. Elmaleh DR, Fischman AJ, Tawakol A, Zhu A, Shoup TM, Hoffmann U, et al. Detection of inflamed atherosclerotic lesions with diadenosine-5′, 5‴-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography. Proc Natl Acad Sci USA 2006;Oct 12; [Epub ahead of print].
11. Isobe S, Tsimikas S, Zhou J, Fujimoto S, Sarai M, Branks MJ, et al. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. J Nucl Med 2006;47(9):1497-1505.
12. Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, Libby P, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006;114:1504-11.
13. Tang T, Howarth SP, Miller SR, Trivedi R, Graves MJ, King-Im JU, et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006;37:2266-70.
14. Fujii K, Mintz GS, Carlier SG, Costa JR Jr, Kimura M, Sano K, et al. Intravascular ultrasound profile analysis of ruptured coronary plaques. Am J Cardiol 2006;98:429-35.